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Abstract We purified an antibacterial substance from larvae of
the saw fly, Acantholyda parki S., and identified its molecular
structure as p-hydroxycinnamaldehyde. We then synthesized it
by reduction of p-hydroxycinnamic acid. The antibacterial
activity of the synthetic p-hydroxycinnamaldehyde was equal to
that of the authentic substance. This molecule was found to have
a broad antibacterial spectrum against not only Gram-negative,
but also Gram-positive bacteria. Furthermore, it showed anti-
fungal activity against Candida albicans. We suggest that this
substance may play a role in the defense system of this insect.
This is the first report of p-hydroxycinnamaldehyde of animal
origin.
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1. Introduction
Dipteran and lepidopteran insects are known to synthesize
a battery of defense proteins in response to bacterial challenge
or body injury [1^5]. These include hemagglutinins and anti-
microbial proteins showing broad spectra of activity against
bacteria and fungi. They are encoded by independent genes
that are selectively activated when insects become infected
[6,7]. The Rel family of transcription factors, including mole-
cules such as NF-UB, may participate in the activation of
these defense protein genes [8,9].
The use of novel bioactive substances from natural sources
for drug development is a promising ¢eld of current research.
Insects constitute the largest group of extant organisms, and
perhaps their individual number account for as much as 80%
of all known fauna. Therefore, they are suggested to be a
useful source of bioactive substances.
As mentioned above, several antimicrobial proteins have
been puri¢ed from insects. However, since the molecular
masses of these compounds usually exceed 3000 Da, it is dif-
¢cult to use them for human therapy. It is necessary to focus
on low-molecular-weight compounds for drug development,
since these are generally more stable and e¡ective, although
few have been reported from insects.
Recently, Leem et al. [10] reported a novel antibacterial
substance named 5-S-GAD derived from an extract of adults
of the £esh £y, Sarcophaga peregrina. This is a small molecule
with a molecular weight of 573, and has been shown to act as
an inhibitor of protein tyrosine kinase [11,12].
Acantholyda parki S., a serious hymenopteran pest of Pinus
koraiensis [13], has been used as a folk medicine in Korea.
Although there has been no report about an antibacterial
substance from this insect, several antibacterial peptides
have been reported from another hymenopteran species,
Apis mellifera (the honeybee) [14^16]. Therefore, we tried to
isolate an antibacterial compound, possibly the counterpart of
5-S-GAD, from A. parki larvae. Although we were unable to
detect any 5-S-GAD-like substance, we succeeded in purifying
to homogeneity an antibacterial substance.
2. Materials and methods
2.1. Insect
A. parki larvae were collected from the Kyungki district of Korea in
February 1997.
2.2. Immunization and preparation of crude extracts of A. parki larvae
One thousand saw £y larvae were anesthetized by keeping them at
4‡C, and then individually pricked with a hypodermic needle that had
been dipped in a suspension of Escherichia coli K12 594 (Strr). The
insects were kept at 27‡C for 24 h, and then collected after being
anesthetized. The anesthetized larvae were homogenized in 10 vol-
umes of 0.1% (v/v) tri£uoroacetic acid containing 10 Wg/ml aprotinin
using an ULTRA-TURRAX T25 homogenizer (IKA-Labortechnik,
Germany). The resulting homogenates were ultracentrifuged for
30 min at 35 000Ug, and the supernatants were ¢ltered through Milli-
pore AA ¢lters (pore size 0.22 Wm). The ¢ltrate was used as a crude
extract for puri¢cation of antibacterial substances.
2.3. Puri¢cation of the antibacterial substance
The crude extract of saw £y larvae was loaded onto an ODS-AM
12S50 cartridge (YMC, Kyoto, Japan). After washing the cartridge
with 0.05% tri£uoroacetic acid, the absorbed material was eluted with
10% (v/v) acetonitrile containing 0.05% tri£uoroacetic acid. Each frac-
tion was concentrated under vacuum to remove the acetonitrile and
tri£uoroacetic acid, and the residue was dissolved in autoclaved dis-
tilled water for measurement of the antibacterial activity. Fractions
showing antibacterial activity were pooled and subjected to reverse-
phase HPLC using a C18 column (YMC-Pack ODS-A, S-5, 120 Aî ,
250U4.6 mm; YMC) equilibrated with 0.1% tri£uoroacetic acid.
After washing the column with 0.1% tri£uoroacetic acid, the absorbed
material was eluted using a linear gradient of 0^20% acetonitrile in
0.1% tri£uoroacetic acid. Fractions showing antibacterial activity were
pooled and subjected to normal-phase HPLC using a TSK gel Car-
bon-500 column (150U4.6 mm; Tosoh, Tokyo, Japan), and the ad-
sorbed material was eluted using a linear gradient of 0^30% acetoni-
trile in 0.1% tri£uoroacetic acid. At this stage, one peak containing
antibacterial activity was eluted from the column. In order to test the
purity of fractions containing high antibacterial activity, they were
pooled and again subjected to reverse-phase HPLC using the same
type of C18 column. The adsorbed material was eluted using a linear
gradient of 10^40% acetonitrile in 0.1% tri£uoroacetic acid. The anti-
bacterial substance was eluted as a single symmetrical peak without
impurity, as detected by UV absorbance at 220 nm. The amount of
antibacterial substance was determined by the method of Lowry et al.
[17], with 4-hydroxycinnamic acid as the standard. All of the HPLC
procedures were carried out using a HP 1050 HPLC system (Hewlett-
Packard, California, USA).
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2.4. Assay of antimicrobial activity
Antibacterial activity was measured in liquid medium using E. coli
K12 594 (Strr) as the indicator bacterium. E. coli was grown in anti-
biotic medium (Difco, Michigan, USA). At the exponential phase of
growth, cells were collected and suspended in 10 mM phosphate
bu¡er (pH 6.0) containing 130 mM NaCl and 0.2% (w/v) bovine
serum albumin at a density of 2.5U108 cells/ml, and the suspension
was then diluted 300-fold with antibiotic medium. The sample solu-
tion in 10 mM phosphate bu¡er (pH 6.0) containing 130 mM NaCl
and 0.05% (w/v) bovine serum albumin (10 Wl) was mixed with 100 Wl
of the bacterial suspension in each well of a 96-well microtiter plate,
and incubated at 37‡C for 5 h. The absorbance at 650 nm was meas-
ured to assess bacterial growth using Emax Microplate Reader Pre-
cision (Molecular Devices Co., California, USA). As a positive con-
trol, cecropin B (Sigma, Missouri, USA) was used.
For the determination of the antimicrobial speci¢city, we used the
various microbial strains. All of the bacterial strains were grown in
antibiotic medium (Difco). Candida albicans KCTC 1940 was grown
in Sabouraud medium (Difco).
2.5. Identi¢cation of p-hydroxycinnamaldehyde
The UV spectrum was analyzed using a Spectronic 3000 ARRAY
spectrophotometer (Milton Roi, New York, USA). The IR spectrum
was recorded using a DIP-140 spectrophotometer (Jasco, Tokyo, Ja-
pan). High-resolution mass spectra were measured using a JMS-SX
102A mass spectrometer (JEOL, Tokyo, Japan) in the electron impact
(+) mode, using per£uorokerosene as the internal standard. All NMR
spectra were recorded using a DMX 600 spectrometer (Bruker, Ger-
many) equipped with a pulse-¢eld gradient system.
2.6. Synthesis of p-hydroxycinnamaldehyde
The method used for synthesis of p-hydroxycinnamaldehyde was
that reported by Duran et al. [18]. p-Hydroxycinnamic acid (2.79
mg) was added to dimethylchloromethyleneammonium chloride
(4.27 mg) in 15 ml of anhydrous tetrahydrofuran and stirred at
room temperature for 30 min. Then, 33.33 ml of 1 M LiAl(OtBu)3H
was added to the reaction mixture with CuI (3.17 g) at 378‡C. For
quenching of the reduction, 4 ml of 6 N HCl was added to the
reaction mixture, and then detection was done using TLC with au-
thentic p-hydroxycinnamaldehyde as an indicator. The resulting reac-
tion mixture was separated by reverse-phase HPLC using C18 column
(YMC-Pack ODS-A, S-5, 120 Aî , 250U4.6 mm; YMC). All chemicals
were purchased from Sigma.
3. Results
3.1. Puri¢cation of an antibacterial substance from
A. parki larvae
We tried to isolate the A. parki counterpart of 5-S-GAD, a
low-molecular-weight antibacterial substance from Sarcopha-
ga, from saw £y larvae using a method based on that de-
scribed by Leem et al. [10]. One major and two minor frac-
tions of antibacterial activity were eluted with 10% acetonitrile
in 0.05% tri£uoroacetic acid during of the ODS-AM 12S50
cartridge column chromatography. We focused on the major
fraction, and tried to purify this substance further. Although
we were unable to detect any A. parki counterpart of 5-S-
GAD, we succeeded in purifying one substance with a yield
of 20%, showing antibacterial activity, to homogeneity by
repeated HPLC procedures (Fig. 1).
3.2. Molecular characterization of the antibacterial substance
The maximal absorption on the UV spectrum was observed
at 233 and 325 nm. The IR absorption at 3120, 1645, 1600^
1500, and 970 cm31 was attributed to phenolic OH, conju-
gated carbonyl, the ole¢nic double bond and aromatic nu-
cleus, and the trans form of the ole¢nic double bond, respec-
tively. The molecular formula of this substance was
determined to be C9H8O2 on the basis of the electron impact
(EI) high-resolution mass spectra (found: m/z 148.0521; cal-
culated: m/z 148.0524), in combination with the NMR spec-
trum. By assignment of the 1H NMR and 13C NMR spectra,
we determined the structure of this antibacterial substance to
be 3-(4-hydroxyphenyl)-2-propenal (Fig. 2). All the NMR
spectral data, summarized in Table 1, were completely identi-
cal to those reported previously. This substance is also called
p-hydroxycinnamaldehyde, which has been puri¢ed from rhi-
zomes of the plant Alpinia galanga [19], and also Sarcophyta
sanguinea [20]. This is the ¢rst report of p-hydroxycinnamal-
dehyde isolated from an animal source.
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Fig. 1. Reverse-phase HPLC pro¢le of antibacterial substance. The
UV absorption at 220 nm was monitored (solid line). Fractions
were concentrated and assayed for antibacterial activity (inset).
Chromatographic conditions were: column, YMC-Pack ODS-A, S-
5, 120 Aî , C18 250U4.6 mm; solution A, 0.1% tri£uoroacetic acid;
solution B, 0.1% tri£uoroacetic acid in 40% acetonitrile; linear gra-
dient 25^100% solution B in solution A (dotted line); £ow rate,
1 ml/min.
Fig. 2. Structure of p-hydroxycinnamaldehyde.
Table 1
Summary of 13C and 1H NMR spectral data for the antibacterial
substance in D2O
Position NC NH
Ole¢nic CH-2 126.1 6.69 (1H, dd, J = 15.7 Hz)
Aromatic CH-3,5 117.6 6.96 (2H, d, J = 8.6 Hz)
Aromatic CH-2,6 132.8 7.66 (2H, d, J = 8.7 Hz)
Ole¢nic CH-1 158.2 7.74 (1H, d, J = 15.6 Hz)
Aromatic C-4 161.1 ^
-CHO 199.5 9.51 (1H, d, J = 8.2 Hz)
The proton signal multiplicity and coupling constant (J = Hz) is given
in parentheses.
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3.3. Synthesis of p-hydroxycinnamaldehyde
As it was di⁄cult to purify p-hydroxycinnamaldehyde in
quantity from saw £y larvae, we tried to synthesize it chemi-
cally. This was done by treating p-hydroxycinnamic acid with
dimethylchloromethyleneammonium chloride and reduction
of the resulting p-hydroxycinnamic dimethylchloromethyl-
eneammonium salt with LiAl(OtBu)3H in the presence of
CuI without protection of the hydroxyl group. The resulting
reaction products were separated by reverse-phase HPLC, and
the major product was identi¢ed as p-hydroxycinnamaldehyde
with a yield of 64%. The synthetic p-hydroxycinnam aldehyde
and the authentic substance coeluted as a single peak when a
mixture of the two was subjected to HPLC. We also con-
¢rmed the structure of synthetic p-hydroxycinnamaldehyde
on the basis of the 1H-NMR and EI-MS spectra. We com-
pared the antibacterial activities of synthetic and authentic p-
hydroxycinnam aldehyde using E. coli as a target bacterium,
and found that they were the same (Fig. 3).
3.4. Antimicrobial speci¢city of p-hydroxycinnamaldehyde
We found that this molecule was e¡ective against both
Gram-negative and Gram-positive bacteria, with similar
IC50 values (0.04^0.08 mM) for E. coli K12 594, Salmonella
enteritidis, E. coli O157 H7 933, Bacillus subtilis KCTC 3069,
and Micrococcus luteus KCTC 1056 under the assay condi-
tions we employed. Furthermore, the substance also exhibited
antifungal activity against Candida albicans KCTC 1940 with
an IC50 value of 0.06 mM. This is probably the ¢rst report of
antimicrobial activities of p-hydroxycinnamaldehyde. The
antimicrobial activity of p-hydroxycinnamaldehyde is sum-
marized in Table 2.
4. Discussion
p-Hydroxycinnamaldehyde has not been found previously
in animals, including insects. However, ethyl trans-cinnamate
has been found as a pheromone in the hairpencils of a number
of lepidopteran species [21]. It is now known that insects are
dependent on their various fruit and nut host species for the
immediate precursors of the hairpencil herbal-scented com-
pounds. However, we were unable to detect p-hydroxycin-
namaldehyde in the leaf of P. koraiensis, which constitutes
the diet of the saw £y, nor were we able to ¢nd any in the
food content of their intestine. These insects generally winter
below ground without feeding from the end of September.
p-Hydroxycinnamaldehyde may be synthesized as a metabo-
lite of some precursor from the leaf of P. koraiensis. Other-
wise, it is possible that p-hydroxycinnamaldehyde may be syn-
thesized from L-phenylalanine in this insect, as is the case in
plants [22,23]. In plants, p-hydroxycinnamaldehyde is a pre-
cursor of lignin, which is an integral cell wall constituent and
e¡ective barrier against plant pathogens [24].
We suggest that this low-molecular-weight substance may
play a role in the defense system of insects. Leem et al. have
reported that 5-S-GAD would be rapidly synthesized upon
infection with bacteria, and would suppress bacterial growth
as a primary response, while the genes for various antibacte-
rial proteins would subsequently be activated in response to
H2O2 produced by 5-S-GAD [10].
p-Hydroxycinnamaldehyde was detected in four times larger
amounts in immunized than in naive saw £ies, suggesting that
it is an inducible defense molecule produced in response to
bacterial infection, integument injury, or both. Therefore we
suggest that this compound may be related to the insect de-
fense system, although many more experiments are needed to
clarify this issue.
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